Iniparib is an irreversible PARP1 inhibitor. Studies show that potential therapeutic agent for the treatment of cancer, including triple-negative breast cancer.
Molecular Spectra
No Data Available
Click here to submit data
References
• O'Shaughnessy, J. et al.: N. Eng. J. Med., 364, 205 (2010)
• Liang, H. et al.: Curr. Breat Cancer Rep., 3, 44 (2010)